Scott Leune Names 2026 Sponsors Selected to Support Dental Practice Growth and Operations 
INmune Bio, Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on Wednesday, November 3
Management to host conference call and webcast at 4:30 pm ET on that dayBoca Raton, Florida, Oct. 25, 2021 (GLOBE...
Panbela Schedules Conference Call on November 10, 2021, to Report 2021 Third Quarter Financial Results
MINNEAPOLIS , Oct. 25, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergic Reactions
First and only orally delivered epinephrine product candidate AQST-109 demonstrates clinical results comparable to autoinjectors (such as EpiPen® and Auvi-Q®)...
Agenus to Provide Corporate Update and Third Quarter 2021 Financial Report
Conference Call on Tuesday, November 9, 2021, at 8:30 a.m. ET LEXINGTON, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Agenus...
Sharps Compliance Acquires Affordable Medical Waste; Enhances Route Based Services and Density in Indiana
HOUSTON, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national...
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA
EWING, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today...
Akari Therapeutics Announces New Data with Nomacopan from its Surface of the Eye Program
Nomacopan eyedrops reduced inflammation more than both standard treatments cyclosporin and the steroid dexamethasone in a model of allergic eye...
Genetic Technologies Reports Q1 FY22 Results
Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarterMELBOURNE, Australia, Oct....
Exagen Inc. Announces $27.2 Million Debt Refinancing
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that...
Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021
The Company will host a Conference Call and Webcast on November 10, 2021, at 8:30 AM ESTCORAL GABLES, Fla., Oct....
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2021 Financial Results
SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical...
American Physician Partners Announces Revenue Cycle Partnership Extension with R1 to Support Its Continued Growth in Emergency Medicine Market
MURRAY, Utah, Oct. 25, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform...
X4 Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021
Earnings Call taking place at 9:05 a.m. ET expected to include discussion of abstracts accepted to the upcoming 63rd American...
Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast
Call scheduled for Thursday, November 11th at 4:30 pm Eastern TimeGARDEN CITY, N.Y., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Beyond...
Allakos Presents Data at ACG 2021 from Prospective Study Showing High Prevalence Rates of Eosinophilic Gastritis and/or Eosinophilic Duodenitis with Systematic Evaluation
– Study shows 45% (181/405) of patients with moderate-to-severe unexplained gastrointestinal symptoms who underwent upper endoscopy with biopsy met the histologic criteria...
Rain Therapeutics Hosting Research and Development (R&D) Day
Tuesday, November 9th at 11:00 am ETNEWARK, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc., (NasdaqGS: RAIN), (“Rain”),...
Amedisys to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference
BATON ROUGE, La., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Mersana Therapeutics Announces Appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program Leadership
Brian DeSchuytner named SVP and Chief Financial OfficerCAMBRIDGE, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN),...
Presenting Sponsor Boosh To Introduce New Shelf Stable Plant-Based Mac & Cheese at Planted Expo
Vancouver, British Columbia--(Newsfile Corp. - October 25, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company")...
Halberd Files Provisional Patent on Breakthrough Obesity Treatment
Jackson Center, Pennsylvania--(Newsfile Corp. - October 25, 2021) - Halberd Corporation (OTC Pink: HALB) announces the filing of a provisional...